Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.

MLA

Gao, Xiao-Ning, et al. “Donor Lymphocyte Infusion for Prevention of Relapse after Unmanipulated Haploidentical PBSCT for Very High-Risk Hematologic Malignancies.” Annals of Hematology, vol. 98, no. 1, Jan. 2019, pp. 185–93. EBSCOhost, https://doi.org/10.1007/s00277-018-3482-7.

APA

Gao, X.-N., Wang, S.-H., Huang, W.-R., Li, F., Li, H.-H., Chen, J., Wang, L.-J., Gao, C.-J., Yu, L., Liu, D.-H., & Lin, J. (2019). Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies. Annals of Hematology, 98(1), 185–193. https://doi.org/10.1007/s00277-018-3482-7

Chicago

Gao, Xiao-Ning, Shu-Hong Wang, Wen-Rong Huang, Fei Li, Hong-Hua Li, Jing Chen, Li-Jun Wang, et al. 2019. “Donor Lymphocyte Infusion for Prevention of Relapse after Unmanipulated Haploidentical PBSCT for Very High-Risk Hematologic Malignancies.” Annals of Hematology 98 (1): 185–93. doi:10.1007/s00277-018-3482-7.